Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators

Behavioural Pharmacology

Volumn 8, Issue 6-7, 1997, Pages 629-638

  Cohen, C ^a   Perrault, Gh ^a   Sanger, D J ^a  

^a SANOFI   (France)

Author keywords

Antidepressant like effects; Calcium channel modulators; Differential reinforcement of low rate schedule; Forced swimming test; Mouse; Rat; Tail suspension test

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMLODIPINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CLENTIAZEM; DILTIAZEM; EMOPAMIL; FELODIPINE; FLUNARIZINE; IMIPRAMINE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NITRENDIPINE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; FORCED SWIMMING TEST; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; RAT;

EID: 0030846894     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199711000-00019     Document Type: Article

References (35)

1. Bidzinski A, Jankowska E and Pucilowski O (1990) Antidepressant-like action of nicardipine, verapamil and hemicholinium-3 injected into the anterior hypothalamus in the rat forced swim test. Pharmacology Biochemistry and Behavior, 36, 795-798.
2. Borsini F and Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology, 94, 147-160.
3. Czyrak A, Mogilnicka E and Maj J (1989) Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats. Neuropharmacology, 28, 229-233.
4. Czyrak A, Mogilnicka E, Siwanowicz J and Maj J (1990) Some behavioral effects of repeated administration of calcium channel antagonists. Pharmacology Biochemistry and Behavior, 35, 557-560.
5. De Vry J, Jentzsch KR and Eckel G (1996) Effects of the L-type calcium channel antagonist nimodipine in animal models of depression. Behavioral Pharmacology, 7, 28.
6. Dubovsky SL (1993) Calcium antagonists in manic-depressive illness. Neuropsychobiology, 27, 184-192.
7. Eccleston D and Cole AJ (1990) Calcium-channel blockade and depressive illness. British Journal of Psychiatry, 156, 889-891.
8. Geoffroy M, Mogilnicka E, Nielsen M and Rafaelsen OJ (1988) Effect of nifedipine on the shuttlebox escape deficit induced by inescapable shock in the rat. European Journal of Pharmacology, 154, 277-283.
9. Höschl C (1991) Do calcium antagonists have a place in the treatment of mood disorders? Drugs, 42, 721-729.
10. Hullett FJ, Potkin SG, Levy AB and Ciasca R (1988) Depression associated with nifedipine-induced calcium channel blockade. American Journal of Psychiatry, 145, 1277-1279.
11. Jackson A, Koek W and Colpaert FC (1995) Can the DRL 72 s schedule selectively reveal antidepressant drug activity? Psychopharmacology, 117, 154-161.
12. Jacques RM and Cox SJ (1991) Verapamil in major (psychotic) depression. British Journal of Psychiatry, 158, 124-125.
13. Janis RA, Silver PJ and Triggle DJ (1987) Drug action and cellular calcium regulation. Advances in Drug Research, 16, 309-591.
14. Kuzmin A, Zvartau E, Gessa GL, Martellotta MC and Fratta W (1992) Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacology Biochemistry and Behavior, 41, 497-500.
15. Martin P, Laurent S, Massol J, Childs M and Puech AJ (1989) Effects of dihydropyridine drugs on reversal by imipramine of helpless behavior in rats. European Journal of Pharmacology, 162, 185-188.
16. McGuire PS and Seiden LS (1980) The effects of tricyclic antidepressants on performance under differential-reinforcement-of-low-rates schedule in rats. Journal of Pharmacology and Experimental Therapeutics, 214, 635-641.
17. Mogilnicka E, Czyrak A and Maj J (1987) Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. European Journal of Pharmacology, 138, 413-416.
18. Mogilnicka E, Czyrak A and Maj J (1988) BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. European Journal of Pharmacology, 151, 307-311.
19. 3H]Amlodipine binding to rat cardiac membranes. Journal of Cardiovascular Pharmacology, 17, 587-592.
20. Palmer GC, Stagnitto ML, Ray RK, Knowles MA, Harvey R and Garske GE (1993) Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-, L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia, 34, 372-380.
21. Perrault G, Morel E, Zivkovic B and Sanger DJ (1992) Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacology Biochemistry and Behavior, 42, 45-47.
22. Pollack MH and Rosenbaum JF (1987) Verapamil in the treatment of recurrent unipolar depression. Biological Psychiatry, 22, 776-779.
23. Pollard GT and Howard JL (1986) Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse-time > 72 s schedule. Psychopharmacology, 89, 253-258.
24. Porsolt RD, Bertin A and Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Archives of International Pharmacodynamics Therapy, 229, 327-336.
25. Pucilowski O (1992) Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology, 109, 12-29.
26. Quatermain D, Hawxhurst A and Ermita B (1993) Effect of the calcium channel blocker amlodipine on memory in mice. Behavioral and Neural Biology, 60, 211-219.
27. Richards JB, Sabol KE and Seiden LS (1993) DRL interresponse-time distributions: quantification by peak deviation analysis. Journal of Experimental and Analytical Behavior, 60, 361-385.
28. Rosenzweig-Lipson S and Barrett JE (1995) Modification of the behavioral effects of (±)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 274, 842-851.
29. Sanger DJ, Key M and Blackman DE (1974) Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement. Psychopharmacologia, 38, 159-171.
30. Seiden LS and O'Donnell JM (1985) Effects of antidepressant drugs on DRL behaviour. In: Behavioural Pharmacology: The Current Status (Eds L.S. Seiden and R.L. Balster), pp. 323-338. Liss, NY.
31. Steru L, Chermat R, Thierry B and Simon P (1985) The Tail Suspension Test: a new method for screening antidepressants in mice. Psychopharmacology, 85, 367-370.
32. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, Simon P and Porsolt RD (1987) The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 11, 659-671.
33. Van der Heyden JAM, Molewijk E and Olivier B (1987) Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology, 92, 127-130.
34. Walden J, Grunze H, Hellhammer D and Berger M (1994) Treatment of depressive episodes with the calcium antagonist nimodipine. Behavioural Pharmacology, 5, 86.
35. Yamada S, Sugimoto N, Uchida S, Deguchi Y and Kimura R (1994) Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors. Journal of Cardiovascular Pharmacology, 23, 466-472.